Hallandale Pharmacy

What Hallandale Pharmacy does

Hallandale Pharmacy is a privately-held compounding pharmacy founded in 2003 and headquartered in Fort Lauderdale, Florida. The company operates from a 60,000 square foot state-of-the-art facility and specializes in customized compounded medications across 13 therapeutic categories, with a core focus on injectable GLP-1 weight management formulations. The flagship product line centers on Semaglutide and Tirzepatide injectable Flex-Dose vials in multiple concentrations (2.5 mg/mL to 15 mg/mL) and vial sizes (1-4 mL), enabling patient-specific dose titration. Adjacent therapeutic areas include hormone replacement therapy, peptide therapy, dermatology, fertility, men's and women's health, IV therapy, sexual wellness, and custom compounds. The pharmacy holds PCAB (Pharmacy Compounding Accreditation Board) accreditation and is an FDA-registered facility.

The business operates a B2B2C distribution model. Healthcare providers register through dedicated portals (start.hallandalerx.com for new providers, LifeFile login portal for existing prescribers) and transmit electronic prescriptions via API integration; medications are then dispensed and shipped directly to patients. The company has expanded its reach through telehealth platform partnerships, notably with Ozari Health, which offers compounded GLP-1 medications at $86/month (Semaglutide) and $120/month (Tirzepatide) — a fraction of brand-name alternatives priced at $1,000+/month. Revenue is generated through per-prescription compounding and dispensing fees. The firm is led by founder and CEO Lucy Anderson, maintains a small corporate headcount (1-10 listed), and has no disclosed parent company, institutional investment, or public funding rounds.

The business is exposed to meaningful regulatory risk. In 2020, the company received an FDA Warning Letter regarding sterile compounding practices, and compounded GLP-1 products face ongoing FDA scrutiny. The combination of significant infrastructure (60,000 sq ft), long operating history, telehealth channel partnerships, and product breadth in a high-demand therapeutic category positions Hallandale as a mid-scale specialized compounding pharmacy, though revenue, ownership, and growth metrics are not publicly disclosed.

Name

Hallandale Pharmacy

Legal name

Hallandale Pharmacy

Website

https://hallandalepharmacy.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

1–10 employees

Short description

Hallandale Pharmacy is a privately-held, PCAB-accredited compounding pharmacy headquartered in Fort Lauderdale, FL. It produces customized injectable GLP-1 medications and other compounded therapies, serving patients nationwide via healthcare provider prescriptions and telehealth platform partnerships.

Ownership category

akta.pro rank

Product category

Compounding Pharmacy Services

NAICS

Pharmacies and Drug Retailers (456110)

SIC

Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA)

Keywords

• Compounding pharmacy services
• GLP-1 medications
• Hormone replacement therapy
• Telehealth pharmacy fulfillment
• Custom peptide formulations

Headquarters

HQ city

Fort Lauderdale

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Prescription Compounding Services: Hallandale Pharmacy generates revenue through compounding and dispensing prescription medications to patients via healthcare provider prescriptions. The pharmacy produces customized medications across multiple therapeutic categories including GLP-1 weight loss medications (Semaglutide, Tirzepatide), hormone replacement therapy, peptide therapy, and other specialty compounds.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Hallandale Pharmacy is a PCAB-accredited compounding pharmacy that produces customized prescription medications for healthcare providers and telehealth partners across therapeutic categories including weight management (compounded Semaglutide and Tirzepatide), hormone replacement, peptide therapy, dermatology, fertility, and IV therapy. The pharmacy operates from a 60,000 square-foot facility in Fort Lauderdale, FL, dispenses Flex-Dose formulations in multiple vial sizes and concentrations, and supports providers through electronic prescription transmission and API-based onboarding.

Product overview

Hallandale Pharmacy is a compounding pharmacy offering a portfolio of customized injectable GLP-1 medications. The core product line centers on Semaglutide and Tirzepatide formulations available in multiple concentrations and vial sizes (1 mL to 4 mL), enabling flexible dose titration for patients. These weight management medications are complemented by the pharmacy's broader compounding services spanning Women's Health, Men's Health, Hormone Replacement, Sexual Wellness, Dermatology, IV Therapy & Supplements, Peptide Therapy, Fertility, Vitality, Custom Compound, Ophthalmology, and Nause treatments. The pharmacy differentiates itself through state-of-the-art 60,000 square foot facilities, PCAB accreditation, fast turnaround times, and clinical support services including electronic prescription platforms.

Differentiator

Problem solved

Functional benefit

Products and services

• Semaglutide Double-Strength Flex-Dose 3 mL Injectable compounded semaglutide at 5 mg/mL in a 3 mL vial, providing a higher-concentration, flexible-dose formulation intended for titration in GLP-1 weight management therapy. Prescribed by healthcare providers and dispensed to patients.
• Semaglutide Flex-Dose 4 mL Injectable compounded semaglutide at 2.5 mg/mL in a 4 mL vial for flexible dose titration in GLP-1 weight management therapy.
• Semaglutide Flex-Dose 3 mL Injectable compounded semaglutide in a 3 mL vial for flexible dosing in weight management treatment.
• Semaglutide Flex-Dose 2 mL Injectable compounded semaglutide in a 2 mL vial for flexible dosing in weight management treatment.
• Tirzepatide Forte Flex-Dose 4 mL High-concentration injectable compounded tirzepatide at 15 mg/mL in a 4 mL vial, offering enhanced dosing flexibility for GLP-1/GIP dual receptor agonist therapy.
• Tirzepatide Flex-Dose 4 mL Injectable compounded tirzepatide at 10 mg/mL in a 4 mL vial for flexible dosing in dual GLP-1/GIP weight management therapy.
• Tirzepatide Flex-Dose 3 mL Injectable compounded tirzepatide in a 3 mL vial for flexible dosing in GLP-1/GIP weight management treatment.
• Tirzepatide Flex-Dose 2 mL Injectable compounded tirzepatide in a 2 mL vial for flexible dosing in weight management treatment.
• Tirzepatide Flex-Dose 1 mL Injectable compounded tirzepatide in a 1 mL vial for flexible dosing in weight management treatment.
• Custom Compounding Services (Women's Health, Men's Health, Hormone Replacement, Sexual Wellness, Dermatology, IV Therapy & Supplements, Peptide Therapy, Fertility, Vitality, Custom Compound, Ophthalmology, Nausea) Custom pharmaceutical compounding services producing personalized prescription medications in 12+ therapeutic categories beyond the core GLP-1 weight management line, including women's and men's health, hormone replacement, sexual wellness, dermatology, IV therapy and supplements, peptide therapy, fertility, vitality, ophthalmology, and nausea treatments. Prescribed by healthcare providers and dispensed to patients.
• Provider Onboarding and Electronic Prescription Fulfillment Service Service for healthcare providers and medical groups to register with the pharmacy (start.hallandalerx.com), transmit prescriptions electronically via the pharmacy's platform and API integration, and have compounded medications dispensed to their patients.
• Patient Refill Request Service Self-serve refill request service for existing patients to request prescription refills of their compounded medications through the pharmacy's partner portal.

Quantifiable outcome

• Compounded GLP-1 medications offered at $86-120/month compared to $1,000+/month for brand-name alternatives

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• Ozari HealthcoreGTM or Marketing Partner · 20 May 2026Ozari Health operates a nationwide telehealth platform offering compounded Semaglutide starting at $86/month and Tirzepatide starting at $120/month. The platform connects patients with licensed providers and partners with Hallandale Pharmacy and VialsRX to fulfill prescriptions, offering patients pharmacy choice and transparent standardized pricing.
• Ozari HealthcoreGTM or Marketing Partner · 19 May 2026Telehealth partnership enables Ozari Health to offer compounded GLP-1 weight-loss medications at significantly reduced prices ($86-120/month vs $1,000+/month brand-name). Hallandale Pharmacy serves as one of multiple compounding pharmacy partners, though FDA scrutiny of compounded GLP-1 products (April 2026) creates regulatory complexity for this partnership.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Hims & Hers Health: Public telehealth platform that has vertically integrated pharmacy fulfillment, including recent offerings of compounded GLP-1s. Represents a broader incumbent moving into Hallandale's compounded GLP-1 space with greater consumer brand recognition and marketing scale.
• Ro (Roman Health): Telehealth platform with vertically integrated pharmacy operations offering compounded treatments including weight management. Comparable as a telehealth-distributed channel for compounded medications that competes with Hallandale's partner pharmacies for prescriber and patient relationships.

Direct peers

• Empower Pharmacy: Large-scale 503A and 503B compounding pharmacy offering custom sterile and non-sterile preparations including weight management, hormone, and peptide therapies. Directly comparable to Hallandale as a high-volume, multi-therapeutic-category compounder serving providers and telehealth platforms.
• Olympia Pharmaceuticals: 503A/503B compounding pharmacy producing custom sterile and non-sterile preparations distributed to providers and clinics nationally. Comparable as a scaled compounder with provider-direct distribution and overlapping therapeutic categories including weight management.
• Wedgewood Pharmacy: Large-scale compounding pharmacy (formerly known for veterinary compounding, now broader) with custom sterile and non-sterile preparations serving prescribers and patients. Comparable in scale, accreditation posture, and provider-direct fulfillment model.
• AnazaoHealth: PCAB-accredited compounding pharmacy offering sterile and non-sterile custom preparations across multiple therapeutic areas. Comparable as a multi-category compounder with provider-facing distribution and digital prescription capabilities.
• Red Rock Pharmacy: Compounding pharmacy providing customized sterile preparations (including GLP-1 weight loss therapies) to providers and patients nationally. Comparable scale and therapeutic breadth to Hallandale with similar provider-driven distribution model.
• VialsRX: Compounding pharmacy explicitly named alongside Hallandale as a partner pharmacy for Ozari Health's telehealth GLP-1 platform. Direct competitor pursuing the same telehealth-distributed compounded GLP-1 model with overlapping product mix.
• Strive Pharmacy: PCAB-accredited compounding pharmacy offering custom sterile injectables including compounded Semaglutide and Tirzepatide via provider and telehealth channels. Closely mirrors Hallandale's GLP-1-centric compounding model with similar B2B2C distribution.

Emerging players

• Custom Medico Pharmacy: Smaller compounding pharmacy focused on custom sterile injectables with provider partnerships. Comparable as a multi-category compounder operating at a smaller scale than Hallandale with similar digital provider integration.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• XX.com/hallandalerx
• LinkedInlinkedin.com/company/hallandale-pharmacy
• Instagraminstagram.com/hallandalepharmacy
• Facebookfacebook.com/HallandalePharmacy

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hallandale Pharmacy